Legal & General Group’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-3,924
| Closed | -$13K | – | 3672 |
|
2021
Q1 | $13K | Hold |
3,924
| – | – | ﹤0.01% | 3313 |
|
2020
Q4 | $10K | Hold |
3,924
| – | – | ﹤0.01% | 3350 |
|
2020
Q3 | $8K | Sell |
3,924
-1,403
| -26% | -$2.86K | ﹤0.01% | 3319 |
|
2020
Q2 | $12K | Hold |
5,327
| – | – | ﹤0.01% | 3271 |
|
2020
Q1 | $13K | Sell |
5,327
-2,281
| -30% | -$5.57K | ﹤0.01% | 3100 |
|
2019
Q4 | $20K | Hold |
7,608
| – | – | ﹤0.01% | 3191 |
|
2019
Q3 | $27K | Hold |
7,608
| – | – | ﹤0.01% | 3022 |
|
2019
Q2 | $26K | Hold |
7,608
| – | – | ﹤0.01% | 3108 |
|
2019
Q1 | $21K | Buy |
7,608
+1,244
| +20% | +$3.43K | ﹤0.01% | 3083 |
|
2018
Q4 | $18K | Hold |
6,364
| – | – | ﹤0.01% | 3122 |
|
2018
Q3 | $26K | Hold |
6,364
| – | – | ﹤0.01% | 3108 |
|
2018
Q2 | $33K | Sell |
6,364
-1,465
| -19% | -$7.6K | ﹤0.01% | 2974 |
|
2018
Q1 | $43K | Sell |
7,829
-3,665
| -32% | -$20.1K | ﹤0.01% | 2827 |
|
2017
Q4 | $95K | Sell |
11,494
-469
| -4% | -$3.88K | ﹤0.01% | 2607 |
|
2017
Q3 | $125K | Buy |
11,963
+1,300
| +12% | +$13.6K | ﹤0.01% | 2526 |
|
2017
Q2 | $119K | Buy |
10,663
+1,022
| +11% | +$11.4K | ﹤0.01% | 2513 |
|
2017
Q1 | $80K | Sell |
9,641
-592
| -6% | -$4.91K | ﹤0.01% | 2669 |
|
2016
Q4 | $71K | Buy |
10,233
+3,267
| +47% | +$22.7K | ﹤0.01% | 2750 |
|
2016
Q3 | $34K | Hold |
6,966
| – | – | ﹤0.01% | 2693 |
|
2016
Q2 | $41K | Buy |
+6,966
| New | +$41K | ﹤0.01% | 2569 |
|